Stay updated on PRS-343 HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 HER2+ Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A banner announces NIH’s transition-related terminology updates, including the use of “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T13:32:08.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision indicator changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:03:28.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:34:06.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, indicating access to the study record is blocked. The added HTML content confirms an access-denied state rather than the study details.
    Difference
    0.5%
    Check dated 2026-09-27T19:44:28.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the usual study record content, replacing the trial details with an error page and related navigation.
    Difference
    18%
    Check dated 2026-09-20T19:22:42.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.5 to v3.6.6, signaling a minor platform or rendering update to the page.
    Difference
    0.1%
    Check dated 2026-08-30T17:01:58.000Z thumbnail image

Stay in the know with updates to PRS-343 HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.